Bank Of New York Mellon Corp Clene Inc. Transaction History

Bank Of New York Mellon Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$2.1 - $4.12 $128,828 - $252,749	-61,347 Closed	0 $0
Q1 2022 May 11, 2022	SELL	$2.42 - $4.42 $1,493 - $2,727	-617 Reduced 1.0%	61,347 $242,000
Q4 2021 Feb 11, 2022	BUY	$3.95 - $7.53 $3,665 - $6,987	928 Added 1.52%	61,964 $254,000
Q3 2021 Nov 12, 2021	BUY	$6.83 - $13.58 $26,008 - $51,712	3,808 Added 6.65%	61,036 $417,000
Q2 2021 Aug 11, 2021	BUY	$6.98 - $13.33 $399,451 - $762,849	57,228 New	57,228 $643,000

7.44M

48.1K

160K

Ticker CLNN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 63,502,000
Market Cap $21M
Description
Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. Its lead drug is CNM-Au8, which is being studied in various clinical trials, including a Phase 2/3 registrational clinical trial for patients with amyotrophic lateral scleros...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.